ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 135 out of 2604

$646K Total Retail Price of All Prescriptions

Rank: 100 out of 2604

629 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,677 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 461 354 1 2
OMEPRAZOLE 336 249 2 5
HYDROCODONE-ACETAMINOPHEN 326 231 S3 3 1
LEVOTHYROXINE SODIUM 307 172 4 4
LISINOPRIL 304 229 5 3
FUROSEMIDE 180 153 6 8
HYDROCHLOROTHIAZIDE 177 161 7 10
ATENOLOL 169 132 8 11
METOPROLOL TARTRATE 168 168 9 9
METFORMIN HCL 153 122 10 7
MELOXICAM 148 109 11 36
CITALOPRAM HBR 145 101 12 18
PREDNISONE 137 114 13 34
AMLODIPINE BESYLATE 133 110 14 6
POLYETHYLENE GLYCOL 3350 131 44 15 42
ATORVASTATIN CALCIUM 121 77 16 19
TRAZODONE HCL 109 84 17 46
FLUOXETINE HCL 108 33 18 49
TAMSULOSIN HCL 108 78 18 30
ALENDRONATE SODIUM 98 55 20 29
GABAPENTIN 87 76 21 12
TRIAMTERENE-HCTZ 81 43 22 55
BUMETANIDE 77 49 23 70
DIVALPROEX SODIUM 75 0 24 81
RANITIDINE HCL 72 46 25 25
MORPHINE SULFATE ER 70 48 S2 26 58
QUINAPRIL HCL 68 66 27 167
ALLOPURINOL 67 65 28 35
METOPROLOL SUCCINATE 67 48 28 17
DIGOXIN 63 56 30 71
QUETIAPINE FUMARATE 63 13 30 66
ABILIFY 63 0 30 130
FLUTICASONE PROPIONATE 61 40 33 31
LOSARTAN POTASSIUM 60 51 34 20
DOXYCYCLINE HYCLATE 60 45 34 122
PREMARIN 60 47 R 34 240
TERAZOSIN HCL 60 36 34 129
CARVEDILOL 59 37 38 26
BETAMETHASONE VALERATE 58 44 39 210
SPIRONOLACTONE 58 47 39 78
VENLAFAXINE HCL ER 57 27 41 107
WARFARIN SODIUM 56 51 42 13
PROAIR HFA 56 41 42 27
HALOPERIDOL 55 45 44 218
SERTRALINE HCL 53 28 45 23
ZOLPIDEM TARTRATE 52 22 46 21
PANTOPRAZOLE SODIUM 52 37 46 64
CYMBALTA 51 34 48 44
OLANZAPINE 50 0 49 115
PRAVASTATIN SODIUM 50 41 49 14
ADVAIR DISKUS 50 47 49 41
AMITRIPTYLINE HCL 50 26 R 49 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.